Middle East & North Africa Veterinary Pharmaceuticals Market will grow in the coming years with an impressive CAGR. The growing affection for pets and increased public knowledge of animal health both will contribute to the growth of the Middle East and North Africa Veterinary Pharmaceuticals market. Additionally, an increase in infectious disorders is expected to promote market expansion in the upcoming years.
Additionally, expanding livestock production, increased meat consumption, and an increase in the incidence of zoonotic illness are driving the growth of the Middle East & North America Veterinary Pharmaceuticals market in the coming years.
In the upcoming years, the Middle East, and North Africa Veterinary Pharmaceuticals market might face challenge from high costs connected with animal services, a lack of infrastructure, rising costs associated with animal testing, and strict restrictions surrounding the use of antibiotics.
Increasing Cases of Infectious Diseases in Animals
The main threat to livestock health is infectious diseases through rickettsia, viruses, bacteria, and fungus. Some protozoan diseases exhibit similar symptoms of infectious diseases and are frequently categorized. Consumption of contaminated food or water with pathogenic (disease-causing) microorganisms as bacteria, viruses, and parasites is the main cause of infectious disorders. After entering the body, they typically start to cause symptoms in the gastrointestinal tract. Contamination is a possibility along the entire food chain, from farm to fork, necessitating management and prevention. Animal diseases are brought on by bacteria, viruses, parasites, fungus, malnutrition, chemical poisons, etc. The Middle East & North Africa market is expected to grow more quickly in the next years due to the rising occurrence of infectious diseases in animals.
Increasing the Adoption of Pets
To aid animals in need of food and shelter, many people are adopting dogs. Pet rescue organizations and animal shelters are overflowing with contented, healthy animals waiting for a home. One strategy to combat puppy mills is pet adoption. Pet owners who purchase animals from a pet shop, an online vendor, or a flea market are moreover purchasing a dog from a puppy mill. Factory-style breeding operations known as puppy mills priorities financial gain over the wellbeing of the canines. Puppy mill animals are kept in abhorrently deficient conditions with inadequate medical attention; as a result, they frequently have severe illnesses and behavioral problems. The growth of the Middle East & North Africa Veterinary Pharmaceuticals market in the anticipated years is being supported by rising concerns over pet adoption and increased awareness of animal healthcare.
Download Free Sample Report
Market Segmentation
Middle East & North Africa Veterinary Pharmaceuticals Market can be segmented by animal and product. Based on animal segment, the market can be further divided into livestock animals, poultry and pets. Based on livestock animals, the market is sub-divided into equine, bovine & camel, ovine, and caprine. Based on poultry, the market is sub-divided into breeders and broilers. Based on pets, the market is sub-divided into canine and feline. Based on product, the market is divided into antibacterial, anthelmintics, anticoccidials, anti-inflammatories, metabolic enhancers, and nutritional supplements. Based on antibacterial, the market is further sub-divided into water soluble powder, oral solutions, feed premixes, injectables, and others. Based on anthelmintics, the market is further sub-segmented into oral powder, oral suspensions, injectables, and others. Based on anticoccidials, the market is further sub-divided into oral solutions, feed premixes, and others.
Market Players
United Company For Veterinary Medicines Industry (UNIVET), MSD Animal Health, Al Mutawwaj Veterinary Pharmaceutical Industries, Boehringer Ingelheim Ltd., VAPCO Manufacturing CO. Ltd., AlQuds Pharmaceutical Group, Megavet Veterinary Medicine LLC, The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco), Saudi Pharmaceutical Industries, Virbac Group are some of the leading players operating in the Middle East & North Africa Veterinary Pharmaceuticals Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | By Animal By Product |
| Country scope | Saudi Arabia, UAE, Kuwait, Qatar, Oman, Bahrain, Egypt, Algeria, Morocco, Tunisia |
| Key companies profiled | United Company For Veterinary Medicines Industry (UNIVET), MSD Animal Health, Al Mutawwaj Veterinary Pharmaceutical Industries, Boehringer Ingelheim Ltd., VAPCO Manufacturing CO. Ltd., AlQuds Pharmaceutical Group, Megavet Veterinary Medicine LLC, The Arab Pesticides and Veterinary Drugs Mfg.Co (Mobedco), Saudi Pharmaceutical Industries, Virbac Group |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
